标题
Monoamine Oxidase B Inhibitors for the Treatment of Parkinsonʼs Disease
作者
关键词
-
出版物
CNS DRUGS
Volume 25, Issue 12, Pages 1061-1071
出版商
Springer Nature
发表日期
2011-11-09
DOI
10.2165/11596310-000000000-00000
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Challenges to the development of disease-modifying therapies in Parkinson’s disease
- (2011) A. H. V. Schapira EUROPEAN JOURNAL OF NEUROLOGY
- A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes
- (2011) Olivier Rascol et al. LANCET NEUROLOGY
- Parkinson disease clinical subtypes and their implications
- (2011) Anthony H. V. Schapira et al. Nature Reviews Neurology
- Why have we failed to achieve neuroprotection in Parkinson's disease?
- (2010) C. Warren Olanow et al. ANNALS OF NEUROLOGY
- Drug selection and timing of initiation of treatment in early Parkinson's disease
- (2010) Anthony H. V. Schapira et al. ANNALS OF NEUROLOGY
- Does 1-(R)-aminoindan Possess Neuroprotective Properties Against Experimental Parkinson's Disease?
- (2010) Orly Weinreb et al. ANTIOXIDANTS & REDOX SIGNALING
- Safinamide in the treatment of Parkinson's disease
- (2010) Anthony HV Schapira EXPERT OPINION ON PHARMACOTHERAPY
- Molecular and clinical prodrome of Parkinson disease: implications for treatment
- (2010) Anthony H. V. Schapira et al. Nature Reviews Neurology
- Rasagiline protects against alpha-synuclein induced sensitivity to oxidative stress in dopaminergic cells
- (2010) K.Y. Chau et al. NEUROCHEMISTRY INTERNATIONAL
- Early versus delayed initiation of entacapone in levodopa-treated patients with Parkinson’s disease: a long-term, retrospective analysis
- (2009) H. Nissinen et al. EUROPEAN JOURNAL OF NEUROLOGY
- Levodopa in the treatment of Parkinson’s disease
- (2009) A. H. V. Schapira et al. EUROPEAN JOURNAL OF NEUROLOGY
- Perspectives on recent advances in the understanding and treatment of Parkinson’s disease
- (2009) A. H. Schapira et al. EUROPEAN JOURNAL OF NEUROLOGY
- The neuroprotective mechanism of 1-(R)-aminoindan, the major metabolite of the anti-parkinsonian drug rasagiline
- (2009) Orit Bar-Am et al. JOURNAL OF NEUROCHEMISTRY
- Movement disorders: advances in cause and treatment
- (2009) Anthony HV Schapira LANCET NEUROLOGY
- Molecular and clinical pathways to neuroprotection of dopaminergic drugs in Parkinson disease
- (2009) A. H.V. Schapira NEUROLOGY
- A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
- (2009) C. Warren Olanow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degeneration
- (2008) Wen Zhu et al. JOURNAL OF NEUROCHEMISTRY
- Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease
- (2008) Robert A. Hauser et al. MOVEMENT DISORDERS
- Neurobiology and treatment of Parkinson's disease
- (2008) Anthony H.V. Schapira TRENDS IN PHARMACOLOGICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More